Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BLU-782 is an inhibitor of activin receptor-like kinase 2 (ALK2) containing an arginine-to-histidine substitution mutation at position 206 (ALK2R206H), an activating mutation found in patients with fibrodysplasia ossificans progressiva (FOP), which is characterized by progressive heterotopic ossification, or diffuse intrinsic pontine glioma (DIPG), which is a type of pediatric brain stem cancer.1 It binds to ALK2R206H (IC50 = ≤10 nM) and reduces phosphorylation of the ALK2 substrate SMAD1 at serine 463 (Ser463) and Ser465 in HEK293 cells expressing ALK2R206H (IC50 = ≤100 nM).
WARNING This product is not for human or veterinary use.
1. Inhibitors of activin receptor-